https://www.selleckchem.com/pr....oducts/Gefitinib.htm
The primary outcome is health seeking behaviour, measured using the Actual Help Seeking Questionnaire, at 6months' follow-up. Data collection will be undertaken at baseline (T, post-intervention-up to 3months (T1), at 6months (T2), 12months (T3) and 24months (T4). The primary analysis will be conducted on those participants who receive MHFA, a per protocol analysis. The study is the first to evaluate the effect of MHFA in the workplace on employees with direct and indirect experience of the intervention, when compared with usual pra
Like
Comment
Share
